Lv4
740 积分 2021-01-15 加入
Obinutuzumab in Refractory Membranous Nephropathy: A Case Series
3个月前
已完结
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
3个月前
已完结
Obinutuzumab in hematologic malignancies: lessons learned to date
3个月前
已完结
Membranous nephropathy: pathogenesis and treatments
3个月前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
3个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
3个月前
已完结
Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real-world study
5个月前
已完结
Clinical development of tri-specific antibodies for immune-oncology
1年前
已完结
Current treatments for oropharyngeal squamous cell carcinoma and the move towards molecular therapy
1年前
已关闭
皖公网安备34019202002308
